Skip to main navigation
Careers
Contact
News
About
Product Pipeline
XEN1101 (FOS)
XEN1101 (PGTCS)
XEN1101 (MDD)
NBI-921352 (NEUROCRINE)
Investors
Header investor menu
Investor Overview
Stock Quote
stock chart
Historic stock lookup
News & Events
Press Releases
Event Calendar
Corporate Governance
Management
BOARD OF DIRECTORS
Committee Composition
FINANCIALS & FILINGS
ANNUAL FINANCIAL REPORTS
Quarterly Results
contact investor relations
Partners
Medical Affairs
Conferences
Publications
Expanded Access Program
About
Product Pipeline
Investors
Partners
Medical Affairs
Careers
Contact
News
Event Details
Xenon Provides Corporate Update / Overview of XEN1101 Presentation from the European Congress on Epileptology
August 29, 2018 at 8:30 AM EDT
Supporting Materials
XEN1101 Presentation from the European Congress on Epileptology
2.2 MB
Xenon Announces Positive XEN1101 Pharmacodynamic Data from Phase 1b TMS Study
Webcast Presentation
Event Details
Title
Xenon Provides Corporate Update / Overview of XEN1101 Presentation from the European Congress on Epileptology
Date / Time
August 29, 2018 at 8:30 AM EDT
Investor Relations
investor overview
stock quote
stock chart
historic stock lookup
Analyst Coverage
news & events
press releases
events calendar
Corporate Governance
Management
Board of Directors
Committee Composition
financials & filings
annual financial reports
Quarterly Results
contact investor relations
Tools
print page
RSS Feeds
e-mail alerts